nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—ADRA2B—Apraclonidine—glaucoma	0.24	0.311	CbGbCtD
Etomidate—ADRA2B—Brimonidine—glaucoma	0.24	0.311	CbGbCtD
Etomidate—ADRA2B—Dipivefrin—glaucoma	0.192	0.249	CbGbCtD
Etomidate—ADRA2B—Clonidine—glaucoma	0.0995	0.129	CbGbCtD
Etomidate—Hypoventilation—Brimonidine—glaucoma	0.00704	0.0459	CcSEcCtD
Etomidate—CYP11B2—ACE Inhibitor Pathway—MAS1—glaucoma	0.00681	0.0971	CbGpPWpGaD
Etomidate—CYP11B2—ACE Inhibitor Pathway—ACE2—glaucoma	0.00516	0.0736	CbGpPWpGaD
Etomidate—Hypoventilation—Clonidine—glaucoma	0.00507	0.033	CcSEcCtD
Etomidate—Bradycardia—Physostigmine—glaucoma	0.00503	0.0328	CcSEcCtD
Etomidate—Respiratory failure—Carteolol—glaucoma	0.00444	0.0289	CcSEcCtD
Etomidate—Respiratory failure—Levobunolol—glaucoma	0.0042	0.0273	CcSEcCtD
Etomidate—Hypoxia—Brimonidine—glaucoma	0.00413	0.0269	CcSEcCtD
Etomidate—Arrhythmia—Dipivefrin—glaucoma	0.00376	0.0245	CcSEcCtD
Etomidate—Convulsion—Physostigmine—glaucoma	0.00373	0.0243	CcSEcCtD
Etomidate—Laryngospasm—Dorzolamide—glaucoma	0.00335	0.0219	CcSEcCtD
Etomidate—Laryngospasm—Pilocarpine—glaucoma	0.00317	0.0206	CcSEcCtD
Etomidate—Hypertension—Dipivefrin—glaucoma	0.00316	0.0206	CcSEcCtD
Etomidate—Apnoea—Brimonidine—glaucoma	0.00309	0.0202	CcSEcCtD
Etomidate—Hypoxia—Clonidine—glaucoma	0.00297	0.0194	CcSEcCtD
Etomidate—Tachycardia—Dipivefrin—glaucoma	0.00292	0.019	CcSEcCtD
Etomidate—Respiratory failure—Brimonidine—glaucoma	0.00267	0.0174	CcSEcCtD
Etomidate—Pain—Dipivefrin—glaucoma	0.00255	0.0166	CcSEcCtD
Etomidate—Respiratory failure—Dorzolamide—glaucoma	0.00255	0.0166	CcSEcCtD
Etomidate—Bradycardia—Metipranolol—glaucoma	0.00241	0.0157	CcSEcCtD
Etomidate—Hiccups—Pilocarpine—glaucoma	0.00237	0.0154	CcSEcCtD
Etomidate—Vomiting—Physostigmine—glaucoma	0.00223	0.0146	CcSEcCtD
Etomidate—Bradycardia—Carteolol—glaucoma	0.00223	0.0145	CcSEcCtD
Etomidate—Laryngospasm—Betaxolol—glaucoma	0.0022	0.0144	CcSEcCtD
Etomidate—Pain—Echothiophate—glaucoma	0.00214	0.0139	CcSEcCtD
Etomidate—Bradycardia—Levobunolol—glaucoma	0.00211	0.0137	CcSEcCtD
Etomidate—Arrhythmia—Carteolol—glaucoma	0.00196	0.0127	CcSEcCtD
Etomidate—Respiratory failure—Clonidine—glaucoma	0.00192	0.0125	CcSEcCtD
Etomidate—Arrhythmia—Carbachol—glaucoma	0.00188	0.0122	CcSEcCtD
Etomidate—SLC2A1—endothelium—glaucoma	0.00185	0.385	CbGeAlD
Etomidate—Arrhythmia—Levobunolol—glaucoma	0.00185	0.012	CcSEcCtD
Etomidate—CYP11B2—Endogenous sterols—CYP1B1—glaucoma	0.00181	0.0258	CbGpPWpGaD
Etomidate—Laryngospasm—Timolol—glaucoma	0.0018	0.0117	CcSEcCtD
Etomidate—Hypertension—Metipranolol—glaucoma	0.00178	0.0116	CcSEcCtD
Etomidate—Respiratory failure—Betaxolol—glaucoma	0.00168	0.0109	CcSEcCtD
Etomidate—Bradycardia—Apraclonidine—glaucoma	0.00156	0.0102	CcSEcCtD
Etomidate—CYP11B1—Endogenous sterols—CYP1B1—glaucoma	0.00156	0.0223	CbGpPWpGaD
Etomidate—SLC2A1—NRF2 pathway—SLC6A13—glaucoma	0.00156	0.0222	CbGpPWpGaD
Etomidate—Convulsion—Methazolamide—glaucoma	0.00149	0.00974	CcSEcCtD
Etomidate—SLC2A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00147	0.021	CbGpPWpGaD
Etomidate—Hypotension—Carteolol—glaucoma	0.00145	0.00947	CcSEcCtD
Etomidate—Hypotension—Carbachol—glaucoma	0.00139	0.00909	CcSEcCtD
Etomidate—Hypotension—Levobunolol—glaucoma	0.00137	0.00895	CcSEcCtD
Etomidate—Arrhythmia—Apraclonidine—glaucoma	0.00137	0.00893	CcSEcCtD
Etomidate—Respiratory failure—Timolol—glaucoma	0.00137	0.00892	CcSEcCtD
Etomidate—Bradycardia—Brimonidine—glaucoma	0.00134	0.00873	CcSEcCtD
Etomidate—Bradycardia—Dorzolamide—glaucoma	0.00128	0.00834	CcSEcCtD
Etomidate—SLC2A1—NRF2 pathway—TXN—glaucoma	0.00128	0.0182	CbGpPWpGaD
Etomidate—Pain—Carbachol—glaucoma	0.00128	0.00832	CcSEcCtD
Etomidate—Bradycardia—Travoprost—glaucoma	0.00127	0.0083	CcSEcCtD
Etomidate—Bradycardia—Brinzolamide—glaucoma	0.00126	0.0082	CcSEcCtD
Etomidate—Pain—Levobunolol—glaucoma	0.00126	0.00819	CcSEcCtD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—CCND2—glaucoma	0.00121	0.0173	CbGpPWpGaD
Etomidate—Bradycardia—Pilocarpine—glaucoma	0.00121	0.00788	CcSEcCtD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.0012	0.0172	CbGpPWpGaD
Etomidate—Arrhythmia—Brimonidine—glaucoma	0.00118	0.00766	CcSEcCtD
Etomidate—Pain—Latanoprost—glaucoma	0.00117	0.00759	CcSEcCtD
Etomidate—SLC2A1—NRF2 pathway—SLC6A1—glaucoma	0.00114	0.0162	CbGpPWpGaD
Etomidate—CYP11B2—ACE Inhibitor Pathway—NOS3—glaucoma	0.00114	0.0162	CbGpPWpGaD
Etomidate—Arrhythmia—Dorzolamide—glaucoma	0.00112	0.00732	CcSEcCtD
Etomidate—Hypertension—Bimatoprost—glaucoma	0.00112	0.00728	CcSEcCtD
Etomidate—SLC2A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.00111	0.0158	CbGpPWpGaD
Etomidate—Arrhythmia—Brinzolamide—glaucoma	0.0011	0.0072	CcSEcCtD
Etomidate—Arrhythmia—Pilocarpine—glaucoma	0.00106	0.00692	CcSEcCtD
Etomidate—Convulsion—Acetazolamide—glaucoma	0.00103	0.00674	CcSEcCtD
Etomidate—Hypertension—Brimonidine—glaucoma	0.00099	0.00645	CcSEcCtD
Etomidate—SLC2A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.00098	0.014	CbGpPWpGaD
Etomidate—Vomiting—Diclofenamide—glaucoma	0.000972	0.00634	CcSEcCtD
Etomidate—Bradycardia—Clonidine—glaucoma	0.000966	0.00629	CcSEcCtD
Etomidate—Vomiting—Carbachol—glaucoma	0.000949	0.00618	CcSEcCtD
Etomidate—Hypertension—Dorzolamide—glaucoma	0.000945	0.00616	CcSEcCtD
Etomidate—Hypertension—Travoprost—glaucoma	0.000941	0.00613	CcSEcCtD
Etomidate—Pain—Apraclonidine—glaucoma	0.000932	0.00607	CcSEcCtD
Etomidate—Hypertension—Brinzolamide—glaucoma	0.000929	0.00605	CcSEcCtD
Etomidate—SLC2A1—NRF2 pathway—TGFB2—glaucoma	0.000928	0.0132	CbGpPWpGaD
Etomidate—Tachycardia—Brimonidine—glaucoma	0.000913	0.00595	CcSEcCtD
Etomidate—SLC2A1—eye—glaucoma	0.000909	0.189	CbGeAlD
Etomidate—Pain—Bimatoprost—glaucoma	0.000904	0.00589	CcSEcCtD
Etomidate—SLC2A1—retina—glaucoma	0.000901	0.187	CbGeAlD
Etomidate—SLC2A1—HIF-2-alpha transcription factor network—VEGFA—glaucoma	0.000899	0.0128	CbGpPWpGaD
Etomidate—Vomiting—Methazolamide—glaucoma	0.000895	0.00583	CcSEcCtD
Etomidate—Hypertension—Pilocarpine—glaucoma	0.000893	0.00582	CcSEcCtD
Etomidate—CYP19A1—Endogenous sterols—CYP1B1—glaucoma	0.000884	0.0126	CbGpPWpGaD
Etomidate—SLC2A1—connective tissue—glaucoma	0.000876	0.182	CbGeAlD
Etomidate—Hypotension—Brimonidine—glaucoma	0.000874	0.0057	CcSEcCtD
Etomidate—Tachycardia—Travoprost—glaucoma	0.000868	0.00566	CcSEcCtD
Etomidate—Tachycardia—Brinzolamide—glaucoma	0.000857	0.00559	CcSEcCtD
Etomidate—Arrhythmia—Clonidine—glaucoma	0.000848	0.00552	CcSEcCtD
Etomidate—SLC2A1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000844	0.012	CbGpPWpGaD
Etomidate—Bradycardia—Betaxolol—glaucoma	0.000841	0.00548	CcSEcCtD
Etomidate—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000841	0.012	CbGpPWpGaD
Etomidate—Hypotension—Dorzolamide—glaucoma	0.000835	0.00544	CcSEcCtD
Etomidate—Hypotension—Travoprost—glaucoma	0.000831	0.00542	CcSEcCtD
Etomidate—CYP11B2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00083	0.0118	CbGpPWpGaD
Etomidate—Tachycardia—Pilocarpine—glaucoma	0.000824	0.00537	CcSEcCtD
Etomidate—Hypotension—Brinzolamide—glaucoma	0.000821	0.00535	CcSEcCtD
Etomidate—Pain—Brimonidine—glaucoma	0.0008	0.00521	CcSEcCtD
Etomidate—GABRA1—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00079	0.0113	CbGpPWpGaD
Etomidate—Hypotension—Pilocarpine—glaucoma	0.000789	0.00514	CcSEcCtD
Etomidate—Pain—Dorzolamide—glaucoma	0.000764	0.00498	CcSEcCtD
Etomidate—Pain—Travoprost—glaucoma	0.000761	0.00496	CcSEcCtD
Etomidate—Pain—Brinzolamide—glaucoma	0.000751	0.00489	CcSEcCtD
Etomidate—SLC2A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000747	0.0106	CbGpPWpGaD
Etomidate—Arrhythmia—Betaxolol—glaucoma	0.000738	0.00481	CcSEcCtD
Etomidate—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000724	0.0103	CbGpPWpGaD
Etomidate—Pain—Pilocarpine—glaucoma	0.000722	0.0047	CcSEcCtD
Etomidate—SLC2A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000718	0.0102	CbGpPWpGaD
Etomidate—CYP11B1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000715	0.0102	CbGpPWpGaD
Etomidate—Vomiting—Apraclonidine—glaucoma	0.000693	0.00451	CcSEcCtD
Etomidate—Bradycardia—Timolol—glaucoma	0.000687	0.00448	CcSEcCtD
Etomidate—CYP11B2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000682	0.00972	CbGpPWpGaD
Etomidate—Pseudoephedrine—TNF—glaucoma	0.000664	0.606	CrCbGaD
Etomidate—Tachycardia—Clonidine—glaucoma	0.000658	0.00429	CcSEcCtD
Etomidate—CYP19A1—FSH signaling pathway—BDNF—glaucoma	0.000651	0.00929	CbGpPWpGaD
Etomidate—CYP19A1—Ovarian Infertility Genes—CCND2—glaucoma	0.000638	0.0091	CbGpPWpGaD
Etomidate—SLC2A1—NRF2 pathway—GSTM1—glaucoma	0.000631	0.009	CbGpPWpGaD
Etomidate—Hypotension—Clonidine—glaucoma	0.00063	0.0041	CcSEcCtD
Etomidate—Vomiting—Acetazolamide—glaucoma	0.00062	0.00404	CcSEcCtD
Etomidate—SLC2A1—Metabolism—CA5A—glaucoma	0.000609	0.00868	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—NARFL—glaucoma	0.000609	0.00868	CbGpPWpGaD
Etomidate—Arrhythmia—Timolol—glaucoma	0.000603	0.00393	CcSEcCtD
Etomidate—CYP11B1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000587	0.00838	CbGpPWpGaD
Etomidate—Pain—Clonidine—glaucoma	0.000577	0.00376	CcSEcCtD
Etomidate—Tachycardia—Betaxolol—glaucoma	0.000573	0.00373	CcSEcCtD
Etomidate—Vomiting—Dorzolamide—glaucoma	0.000568	0.0037	CcSEcCtD
Etomidate—Vomiting—Brinzolamide—glaucoma	0.000558	0.00364	CcSEcCtD
Etomidate—SLC2A1—Disease—LRP12—glaucoma	0.000551	0.00786	CbGpPWpGaD
Etomidate—Hypotension—Betaxolol—glaucoma	0.000548	0.00357	CcSEcCtD
Etomidate—SLC2A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	0.000538	0.00768	CbGpPWpGaD
Etomidate—Vomiting—Pilocarpine—glaucoma	0.000537	0.0035	CcSEcCtD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000529	0.00754	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—MMP9—glaucoma	0.00051	0.00727	CbGpPWpGaD
Etomidate—CYP19A1—Tryptophan metabolism—CYP1B1—glaucoma	0.000508	0.00724	CbGpPWpGaD
Etomidate—Hypertension—Timolol—glaucoma	0.000507	0.0033	CcSEcCtD
Etomidate—Pain—Betaxolol—glaucoma	0.000502	0.00327	CcSEcCtD
Etomidate—SLC2A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000498	0.00711	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—GSTT1—glaucoma	0.000454	0.00648	CbGpPWpGaD
Etomidate—Hypotension—Timolol—glaucoma	0.000448	0.00292	CcSEcCtD
Etomidate—Fenoprofen—PTGS2—glaucoma	0.000433	0.395	CrCbGaD
Etomidate—Vomiting—Clonidine—glaucoma	0.000429	0.00279	CcSEcCtD
Etomidate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000411	0.00586	CbGpPWpGaD
Etomidate—Pain—Timolol—glaucoma	0.00041	0.00267	CcSEcCtD
Etomidate—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000405	0.00578	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—GSTT1—glaucoma	0.000392	0.00558	CbGpPWpGaD
Etomidate—Vomiting—Betaxolol—glaucoma	0.000373	0.00243	CcSEcCtD
Etomidate—GABRB2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000365	0.0052	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000365	0.0052	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—CYP1B1—glaucoma	0.000362	0.00516	CbGpPWpGaD
Etomidate—CYP11B2—Metapathway biotransformation—CYP1B1—glaucoma	0.000357	0.00509	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HEYL—glaucoma	0.000355	0.00506	CbGpPWpGaD
Etomidate—SLC2A1—Disease—FGFR1OP—glaucoma	0.000355	0.00506	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—TP53—glaucoma	0.000346	0.00494	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000341	0.00486	CbGpPWpGaD
Etomidate—ADRA2B—Platelet Aggregation (Plug Formation)—FN1—glaucoma	0.000338	0.00483	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000338	0.00482	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000334	0.00476	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000334	0.00476	CbGpPWpGaD
Etomidate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000333	0.00475	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CA5A—glaucoma	0.000318	0.00454	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NARFL—glaucoma	0.000318	0.00454	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—CYP1B1—glaucoma	0.000312	0.00445	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000312	0.00445	CbGpPWpGaD
Etomidate—CYP11B1—Metapathway biotransformation—CYP1B1—glaucoma	0.000308	0.00439	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000305	0.00435	CbGpPWpGaD
Etomidate—Vomiting—Timolol—glaucoma	0.000305	0.00199	CcSEcCtD
Etomidate—SLC2A1—Metabolism—CA1—glaucoma	0.000297	0.00424	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000292	0.00416	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000291	0.00416	CbGpPWpGaD
Etomidate—CYP19A1—Ovarian Infertility Genes—CDKN1B—glaucoma	0.00029	0.00413	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—GSTM1—glaucoma	0.000289	0.00413	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CTSA—glaucoma	0.000288	0.00411	CbGpPWpGaD
Etomidate—CYP11B2—Metapathway biotransformation—GSTM1—glaucoma	0.000285	0.00407	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000283	0.00404	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000281	0.004	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—SLC6A13—glaucoma	0.00028	0.00399	CbGpPWpGaD
Etomidate—CYP19A1—connective tissue—glaucoma	0.000277	0.0575	CbGeAlD
Etomidate—CYP11B1—Metabolism—CA5A—glaucoma	0.000274	0.00391	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NARFL—glaucoma	0.000274	0.00391	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CA2—glaucoma	0.000272	0.00388	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000267	0.00381	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000267	0.00381	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000267	0.0038	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—SLC6A13—glaucoma	0.000256	0.00365	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—NOS3—glaucoma	0.000254	0.00362	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—GSTM1—glaucoma	0.000249	0.00356	CbGpPWpGaD
Etomidate—CYP11B1—Metapathway biotransformation—GSTM1—glaucoma	0.000246	0.00351	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000244	0.00348	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000241	0.00343	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000225	0.00321	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—SLC6A13—glaucoma	0.000223	0.00319	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—GSTT1—glaucoma	0.000222	0.00316	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HDAC9—glaucoma	0.000222	0.00316	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000213	0.00305	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000206	0.00294	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—SLC6A1—glaucoma	0.000205	0.00292	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—OPN4—glaucoma	0.000203	0.0029	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000203	0.00289	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—TXN—glaucoma	0.000192	0.00273	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—SLC6A1—glaucoma	0.000187	0.00267	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—PTGFR—glaucoma	0.000183	0.00261	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00018	0.00257	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—CYP1B1—glaucoma	0.000177	0.00252	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—CYP1B1—glaucoma	0.000174	0.00249	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000165	0.00236	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—SLC6A1—glaucoma	0.000164	0.00233	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NARFL—glaucoma	0.000156	0.00222	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CA5A—glaucoma	0.000156	0.00222	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CA1—glaucoma	0.000156	0.00222	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000154	0.00219	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000151	0.00216	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CTSA—glaucoma	0.000151	0.00215	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00015	0.00214	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GSTT1—glaucoma	0.000149	0.00212	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000145	0.00207	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CA2—glaucoma	0.000142	0.00203	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—GSTM1—glaucoma	0.000141	0.00202	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—GSTM1—glaucoma	0.000139	0.00199	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000139	0.00198	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000139	0.00198	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000137	0.00196	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—NGF—glaucoma	0.000134	0.00191	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CA1—glaucoma	0.000134	0.00191	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000134	0.0019	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000133	0.0019	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CTSA—glaucoma	0.00013	0.00185	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CA2—glaucoma	0.000123	0.00175	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.00012	0.00172	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00012	0.00171	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.00012	0.00171	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.00012	0.00171	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CDKN2B—glaucoma	0.000119	0.0017	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYP1B1—glaucoma	0.000118	0.00169	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ABCA1—glaucoma	0.000118	0.00169	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000116	0.00166	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—OPN4—glaucoma	0.000115	0.00164	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.00011	0.00157	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—OPN4—glaucoma	0.000104	0.00149	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PTGFR—glaucoma	0.000104	0.00148	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000101	0.00144	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TXN—glaucoma	0.0001	0.00143	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MTHFR—glaucoma	9.99e-05	0.00142	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GSTM1—glaucoma	9.46e-05	0.00135	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PTGFR—glaucoma	9.4e-05	0.00134	CbGpPWpGaD
Etomidate—SLC2A1—Disease—APOE—glaucoma	9.3e-05	0.00133	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—SMO—glaucoma	9.24e-05	0.00132	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CAV1—glaucoma	9.21e-05	0.00131	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.14e-05	0.0013	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.06e-05	0.00129	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LRP12—glaucoma	8.9e-05	0.00127	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.79e-05	0.00125	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—C3—glaucoma	8.79e-05	0.00125	CbGpPWpGaD
Etomidate—SLC2A1—Disease—BAD—glaucoma	8.66e-05	0.00124	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TXN—glaucoma	8.64e-05	0.00123	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—MTHFR—glaucoma	8.36e-05	0.00119	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—FN1—glaucoma	8.1e-05	0.00116	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	8e-05	0.00114	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TGFB2—glaucoma	7.92e-05	0.00113	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.88e-05	0.00112	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.81e-05	0.00111	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—APOE—glaucoma	7.79e-05	0.00111	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTT1—glaucoma	7.77e-05	0.00111	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CAV1—glaucoma	7.71e-05	0.0011	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CA1—glaucoma	7.59e-05	0.00108	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CTSA—glaucoma	7.36e-05	0.00105	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	6.99e-05	0.000996	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	6.97e-05	0.000993	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NOS3—glaucoma	6.97e-05	0.000993	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CA2—glaucoma	6.95e-05	0.000991	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.79e-05	0.000968	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.79e-05	0.000968	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTT1—glaucoma	6.7e-05	0.000955	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—VEGFA—glaucoma	6.41e-05	0.000914	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTGS2—glaucoma	6.37e-05	0.000909	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.27e-05	0.000894	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ABCA1—glaucoma	6.19e-05	0.000883	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP1B1—glaucoma	6.19e-05	0.000883	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—OPN4—glaucoma	6.17e-05	0.00088	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—EDN1—glaucoma	6.09e-05	0.000868	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CDKN1B—glaucoma	6.03e-05	0.000861	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SOD1—glaucoma	6e-05	0.000856	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—NOS3—glaucoma	5.83e-05	0.000832	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HEYL—glaucoma	5.73e-05	0.000818	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTGFR—glaucoma	5.55e-05	0.000792	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TNF—glaucoma	5.49e-05	0.000783	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.4e-05	0.00077	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ABCA1—glaucoma	5.34e-05	0.000761	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP1B1—glaucoma	5.34e-05	0.000761	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTGS2—glaucoma	5.34e-05	0.000761	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—C3—glaucoma	5.32e-05	0.000759	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—glaucoma	5.26e-05	0.000751	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTM1—glaucoma	4.95e-05	0.000706	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TXN—glaucoma	4.89e-05	0.000698	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—SMO—glaucoma	4.74e-05	0.000676	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—glaucoma	4.64e-05	0.000661	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MMP1—glaucoma	4.58e-05	0.000653	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.47e-05	0.000637	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.42e-05	0.000631	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—CAV1—glaucoma	4.39e-05	0.000626	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—MTHFR—glaucoma	4.37e-05	0.000624	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RPTOR—glaucoma	4.35e-05	0.00062	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTM1—glaucoma	4.27e-05	0.000608	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NCK2—glaucoma	4.21e-05	0.0006	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—FN1—glaucoma	4.18e-05	0.000596	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APOE—glaucoma	4.07e-05	0.000581	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CAV1—glaucoma	4.03e-05	0.000575	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTT1—glaucoma	3.79e-05	0.000541	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MTHFR—glaucoma	3.77e-05	0.000538	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HDAC9—glaucoma	3.58e-05	0.00051	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APOE—glaucoma	3.51e-05	0.000501	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CAV1—glaucoma	3.48e-05	0.000496	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—EDN1—glaucoma	3.44e-05	0.000491	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS3—glaucoma	3.32e-05	0.000473	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EDN1—glaucoma	3.12e-05	0.000446	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.06e-05	0.000436	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NOS3—glaucoma	3.05e-05	0.000435	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ABCA1—glaucoma	3.02e-05	0.000431	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP1B1—glaucoma	3.02e-05	0.000431	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—C3—glaucoma	3.01e-05	0.000429	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SMO—glaucoma	2.8e-05	0.000399	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—glaucoma	2.79e-05	0.000398	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—C3—glaucoma	2.73e-05	0.000389	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NOS3—glaucoma	2.63e-05	0.000375	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NTRK2—glaucoma	2.56e-05	0.000365	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTM1—glaucoma	2.42e-05	0.000345	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—glaucoma	2.4e-05	0.000343	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VEGFA—glaucoma	2.39e-05	0.000341	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NGFR—glaucoma	2.2e-05	0.000313	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MTHFR—glaucoma	2.14e-05	0.000305	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NTRK1—glaucoma	2.09e-05	0.000298	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOE—glaucoma	1.99e-05	0.000284	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CAV1—glaucoma	1.97e-05	0.000281	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN2B—glaucoma	1.92e-05	0.000274	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EDN1—glaucoma	1.85e-05	0.000263	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—glaucoma	1.81e-05	0.000258	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NGF—glaucoma	1.7e-05	0.000242	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—C3—glaucoma	1.61e-05	0.00023	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOE—glaucoma	1.5e-05	0.000214	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NOS3—glaucoma	1.49e-05	0.000212	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CAV1—glaucoma	1.49e-05	0.000212	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FN1—glaucoma	1.42e-05	0.000202	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—BAD—glaucoma	1.4e-05	0.0002	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS2—glaucoma	1.36e-05	0.000194	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOS3—glaucoma	1.12e-05	0.00016	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN1B—glaucoma	9.74e-06	0.000139	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MMP9—glaucoma	9.02e-06	0.000129	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—glaucoma	8.1e-06	0.000116	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—glaucoma	6.12e-06	8.73e-05	CbGpPWpGaD
